Endonovo Therapeutics, Inc. (ENDV): NT 10-Q filed Aug 15, 2022

Form type

NT 10-Q

Filing date

Aug 15, 2022

Accession number

0001493152-22-022631

Filer

Endonovo Therapeutics, Inc. (CIK 1528172)